Notably, a pronounced up-regulation of CD177 was observed on basophils from COVID-19 patients, and the magnitude of its expression was comparable to the expression of CD177 in CD16bright neutrophils (SI Appendix, Fig. S5C). Here, CD177 is linked to COVID-19.